A study of lichen planus and its association with hepatitis C infection  by Strak, Sarkis K. et al.
Taibah University
Journal of Taibah University Medical Sciences (2015) 10(2), 222e226Journal of Taibah University Medical Sciences
www.sciencedirect.comOriginal ArticleA study of lichen planus and its association with hepatitis
C infection
Sarkis K. Strak, FRCP a, Khalil I. Al-Hamdi, FRCP a and
Majid H. Alabbood, CABMSb,*
aBasra Medical College, Iraq
bAbul Khasib Hospital, Basra, IraqReceived 4 February 2014; revised 10 June 2014; accepted 26 August 2014; Available online 15 November 2014*
Pee
165
Pro
(htﺺﺨﻠﻤﻟﺍ
ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺍﻭﺢﻄﺴﻤﻟﺍﺯﺍﺰﺤﻟﺍﻦﻴﺑﺔﻗﻼﻌﻟﺍﻥﺇ:ﺚﺤﺒﻟﺍﻑﺪﻫ
ﻲﻓﺍﺮﻐﺟﻦﻳﺎﺒﺗﺪﺟﻮﻳﻦﻜﻟﻭ.ﺔﻴﻤﻠﻌﻟﺍﺕﺎﻳﺭﻭﺪﻟﺍﻲﻓﻊﺳﻮﻣﻞﻜﺸﺑﺎﻫﺮﺸﻧﻖﺒﺳﺪﻗ“ﺝ”
ﻦﻴﺑ“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺎﺑﺓﺭﻮﺸﻨﻤﻟﺍﺕﻻﺎﺤﻟﺍﺐﻠﻏﻷﻊﺳﺍﻭ
ﻦﻴﺑﺔﻗﻼﻌﻟﺍﺪﻳﺪﺤﺘﻟﺔﺳﺍﺭﺪﻟﺍﻩﺬﻫﺖﻳﺮﺟﺃ.ﺢﻄﺴﻤﻟﺍﺯﺍﺰﺤﻟﺍﺀﺍﺪﺑﻦﻴﺑﺎﺼﻤﻟﺍﻰﺿﺮﻤﻟﺍ
ﻲﻓﻦﻴﻴﻗﺍﺮﻌﻟﺍﻰﺿﺮﻤﻠﻟ“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺍﻭﺢﻄﺴﻤﻟﺍﺯﺍﺰﺤﻟﺍ
.(ﻕﺍﺮﻌﻟﺍﺏﻮﻨﺟ)ﺓﺮﺼﺒﻟﺍﺔﻈﻓﺎﺤﻣ
ﺮﺑﻮﺘﻛﺃﻰﻟﺇﻡ٨٠٠٢ﺮﻳﺎﻨﻳﻦﻣﺢﻄﺴﻣﺯﺍﺰﺣﺔﻟﺎﺣ٧٩ﺺﻴﺨﺸﺗﻢﺗ:ﺚﺤﺒﻟﺍﻕﺮﻃ
ﺮﻫﺎﻈﻤﻟﺍﻰﻠﻋﺍﺩﺎﻤﺘﻋﺇﺍﺮﻛﺫ(٪٥٬١٥)٠٥ﻭﻰﺜﻧﺃ(٪٥٬٨٤)٧٤،ﻡ٩٠٠٢
ﺪﻨﻋﺔﻋﺰﺨﻟﺍﻦﻋﺔﺠﺗﺎﻨﻟﺍﺔﻴﺟﺫﻮﻤﻨﻟﺍﺔﻴﺠﻴﺴﻨﻟﺍﺺﺋﺎﺼﺨﻟﺍﻰﻠﻋﻭ،ﺓﺰﻴﻤﻤﻟﺍﺔﻳﺮﻳﺮﺴﻟﺍ
ﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﻻﺓﺩﺎﻀﻤﻟﺍﻡﺎﺴﺟﻷﺍﺩﻮﺟﻮﻟﻰﺿﺮﻤﻟﺍﺺﺤﻓﻢﺗ.ﺓﺭﻭﺮﻀﻟﺍ
ﻦﻣﺔﻄﺑﺎﻀﻟﺍﺔﻋﻮﻤﺠﻤﻟﺍﺖﻧﻮﻜﺗ.ﺍﺰﻴﻟﺇﻦﻣﺚﻟﺎﺜﻟﺍﻞﻴﺠﻟﺍﺔﻄﺳﺍﻮﺑ“ﺝ”ﻦﻣﺰﻤﻟﺍ
ﻱﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺎﺑﺔﺑﺎﺻﻹﺎﺑﻢﻬﺼﺤﻓﻢﺗﻡﺪﻟﺎﺑﻦﻴﻋﺮﺒﺘﻤﻟﺍﺀﺎﺤﺻﻷﺍﻦﻣ٠٧٠٢
.ﺓﺮﺼﺒﻟﺍﻲﻓﻱﺰﻛﺮﻤﻟﺍﻡﺪﻟﺍﻚﻨﺑﻲﻓ“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍ
“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﻻﺓﺩﺎﻀﻤﻟﺍﻡﺎﺴﺟﻷﺍﻦﻋﻒﺸﻜﻟﺍﻢﺗ:ﺞﺋﺎﺘﻨﻟﺍ
ﻦﻣﺔﻄﺑﺎﻀﻟﺍﺔﻋﻮﻤﺠﻤﻟﺎﺑﺔﻧﺭﺎﻘﻣﺮﻴﺜﻜﺑﻰﻠﻋﺃﺍﺬﻫﻥﺎﻛ.ﺕﻻﺎﺣ(٪١٬٣)٣ﺪﻨﻋ
ﺕﺎﺻﻮﺤﻓﻲﻓﺢﺿﺍﻭﻑﻼﺘﺧﺍﻙﺎﻨﻫﻦﻜﻳﻢﻟ.(٢٠٠.٠¼ﺏﺔﻤﻴﻗ)ﻡﺪﻟﺎﺑﻦﻴﻋﺮﺒﺘﻤﻟﺍ
ﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺎﺑﻦﻴﺑﺎﺼﻤﻟﺍﻰﺿﺮﻤﻟﺍﻦﻴﺑﺲﻨﺠﻟﺍﻭ،ﺮﻜﺴﻟﺍﺔﺒﺴﻧ،ﺪﺒﻜﻟﺍﻒﺋﺎﻇﻭ
.ﻦﻴﺑﺎﺼﻤﻟﺍﺮﻴﻏﻦﻴﺑﻭ“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍ
ﻰﺿﺮﻤﻟﺍﻦﻴﺑ“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺍﺭﺎﺸﺘﻧﺍﻥﺎﻛ:ﺕﺎﺟﺎﺘﻨﺘﺳﻻﺍ
ﻭﺪﺒﻳ.ﺔﻄﺑﺎﻀﻟﺍﺔﻋﻮﻤﺠﻤﻟﺍﻦﻣﺮﻴﺜﻜﺑﻰﻠﻋﺃﺢﻄﺴﻤﻟﺍﺯﺍﺰﺤﻟﺎﺑﻦﻴﺑﺎﺼﻤﻟﺍﻦﻴﻴﻗﺍﺮﻌﻟﺍ
ﻦﻴﺑﺢﻄﺴﻤﻟﺍﺯﺍﺰﺤﻟﺍﻭ“ﺝ”ﻦﻣﺰﻤﻟﺍﻲﺳﻭﺮﻴﻔﻟﺍﺪﺒﻜﻟﺍﺏﺎﻬﺘﻟﺍﻦﻴﺑﺔﻗﻼﻋﻙﺎﻨﻫﻥﺃ
ﺕﺍﺫﺖﺴﻴﻟﺪﺒﻜﻟﺍﻒﺋﺎﻇﻭﺕﺎﺻﻮﺤﻓﻦﻜﻟﻭ.ﺓﺮﺼﺒﻟﺍﺔﻨﻳﺪﻤﺑﻦﻴﻴﻗﺍﺮﻌﻟﺍﻰﺿﺮﻤﻟﺍCorresponding address: Abul Khasib Hospital, Basra, Iraq.
E-mail: dr_majid79@yahoo.com (M.H. Alabbood)
r review under responsibility of Taibah University.
Production and hosting by Elsevier
8-3612  2014 The Authors.
duction and hosting by Elsevier Ltd on behalf of Taibah Universit
tp://creativecommons.org/licenses/by-nc-nd/4.0/). http://dx.doi.org/10ﺃﻫﻤﻴﺔﻋﻨﺪﻓﺤﺺﺍﻟﺘﻬﺎﺏﺍﻟﻜﺒﺪﺍﻟﻔﻴﺮﻭﺳﻲﺍﻟﻤﺰﻣﻦ”ﺝ“ﻋﻨﺪﻣﺮﺿﻰﺍﻟﺤﺰﺍﺯ
ﺍﻟﻤﺴﻄﺢ.
ﺍﻟﻜﻠﻤﺎﺕﺍﻟﻤﻔﺘﺎﺣﻴﺔ:ﺍﻟﺘﻬﺎﺏﺍﻟﻜﺒﺪ”ﺝ“;ﺍﻟﺤﺰﺍﺯﺍﻟﻤﺴﻄﺢ;ﺇﻟﻴﺰﺍ;ﻓﺤﻮﺻﺎﺕﻭﻇﺎﺋﻒ
ﺍﻟﻜﺒﺪ
Abstract
Objectives: The association of lichen planus with chronic
hepatitis C virus (HCV) has been widely reported in the
literature. However, there are wide geographical varia-
tions in the reported prevalence of HCV infection in
patients with lichen planus. This study was conducted to
determine the association of lichen planus with HCV in
Iraqi patients in Basra governorate (southern Iraq).
Methods: From January 2008 to October 2009, 97 cases
of lichen planus, 47 women (48.5%) and 50 men (51.5%)
were diagnosed on the basis of characteristic clinical
features, and if necessary, typical histological findings on
biopsy. The patients were screened for the presence of
anti-HCV antibodies by third generation ELISA. The
control group (2070 person) consisted of healthy blood
donors who were screened for HCV in the Central Blood
Bank of Basra.
Results: Anti-HCV antibodies were detected in 3 (3.1%)
cases. This was significantly higher in blood donors (p
value ¼ 0.002). A statistically significant association was
demonstrated between lichen planus and hepatitis C virus
infection. Liver function tests, plasma glucose and gender
were not significantly different between HCV infected
and non-infected patients.y. This is an open access article under the CC BY-NC-ND license
.1016/j.jtumed.2014.08.001
S.K. Strak et al. 223Conclusions: The prevalence of HCV among Iraqi
patients with lichen planus (3.1%) was significantly
higher than in the control group (0.14%). It seems that
there is an association between HCV and lichen planus
among Iraqi patients in Basra city; however, liver func-
tion tests are not pivotal means in screening for HCV in
lichen planus patients.
Keywords: Association; Hepatitis C; Lichen planus
 2014 The Authors.
Production and hosting by Elsevier Ltd on behalf of Taibah
University. This is an open access article under the CC BY-
NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Lichen planus (LP), which was firstly described in 1869 by
Jonathan Hutchinson, is a unique inflammatory cutaneous
and mucous membrane reaction pattern of unknown aeti-
ology characterized by small violaceous flat angular scaly
shiny pruritic papules and plaques on the skin and white
papules in the mouth.1,2
There are several clinical forms of LP; actinic, annular,
atrophic, erosive, follicular (lichen planopilaris), guttate,
hypertrophic, linear, papular and vesiculobullous. Skin
lesions are characterized by a white lace-like pattern
(Wickham’s striae) on papules and are almost pathogno-
monic of lichen planus. Mucous membrane involvement is
seen in 40e60% of patients with skin lesion. Twenty
percent of patients have mucous membrane lesions only.1
The mucosal lesion is usually asymptomatic and women
outnumber men by more than 2:1.3 Ulcerative mucosal
disease is premalignant. Koebner’s phenomenon
(appearance of lesions in areas of trauma) is often seen.4,5
The cause of LP is unclear. The most acceptable hy-
pothesis implies a viral cause, immunological or emotional
stress. Lichenoid eruptions include drug induced, chemical,
bacterial and post bone marrow transplantation. Lichenoid
drug eruptions are morphologically similar to LP and can be
differentiated by drug history only.3,6
Hepatitis C virus (HCV) is a single-stranded RNA flavi-
virus that replicates in hepatocytes and peripheral blood
mononuclear cells.6
The diagnosis is based on detection of antibodies against
HCV (anti-HCV). The third-generation enzyme-linked
immunosorbent assay (ELISA) has 99% sensitivity in
detecting total antibodies with 94% specificity and can be
confirmed by direct detection using HCV RNA.
In recent years it has become known that HCV induces a
broad spectrum of extrahepatic manifestations including
porphyria cutanea tarda and LP. These dermatological
manifestations may serve as an early marker for HCV that
may save lives. Therefore, evaluating the potential clinical
role of LP in diagnosing HCV infection seems to be an
extremely practical and pivotal task.8
The association of LP and HCV is uncertain and contro-
versial in literature because the prevalence of HCV infection
in patients with LP varies considerably from onegeographical area to another ranging from 4% in northern
France to 62% in Japan while studies from Great Britain
failed to reveal any association.9e11 It has been suggested that
the geographical origin of patients would be an important
factor in HCV prevalence among patient with LP.12
The pathogenesis of this association is uncertain and there
are several explanations that had been suggested by several
researchers. One of the more often cited explanation is the
suggestion that HCV infection precipitates an autoimmune
process.13 LP appears to be related to the pattern of immune
dysregulation induced by HCV. The mechanism of HCV
induced lichen planus is possibly related to the viral
replication in lymphocytes14 and it is well known that one
of the characteristic histological features of LP is band like
lymphocytic infiltration in the papillary dermis or possibly
HCV is related in a way or another to the basal cell layer
of the epidermis to which the lymphocytic band like
infiltrate seems to be directed and once these cells are
destroyed, the infiltrate descends down to the upper
dermis. This point needs to be further clarified in more
specified studies.
The controversies and uncertainties regarding the asso-
ciation of LP and chronic HCV inspired us to conduct this
study in a group of patients in Basra (southern Iraq).Materials and Methods
From January 2008 to October 2009, a total of 97 patients
with lichen planus were enrolled in a case control study, 50
males (51.5%) and 47 females (48.5%) with an age ranging
from 5 to 77-year-old (mean age 34.2  14.7 years). Male:
female was 1:1.06.
This study was carried out at the dermatology clinic of
both Al-Sadir teaching and Basra general hospitals.
The demographic data such as age, gender and informa-
tion including type of lesion, site of involvement and other
associated lesions were collected using a checklist after tak-
ing the patients’ consent.
Patients with a possible drug induced lichenoid eruptions,
those who have chronic hepatitis B infection and a history of
alcohol consumption were excluded from the study. All of
the 97 patients were screened for the presence of serological
evidence of HCV using the 3rd generation ELISA kit for
detection of antibodies to human HCV, Murex anti-HCV
ELISA version 4.0 (Abbott corporation, Kyalami Business
pork, South Africa). All of the patients were also screened for
hepatitis B infection using a detection kit for hepatitis Bs
antigen, Murex HBs Ag version 4.0 (Abbott corporation,
Kyalami Business pork, South Africa).
A total of 2070 apparently healthy Iraqi blood donors
from both sexes were selected from the records of Central
Blood Bank of Basra and have been used as a control group.
They had already been tested for HCV antibodies using the
same technique that was used in testing the cases.
All of the patients were diagnosed clinically by a derma-
tologist. In suspicious cases 27patients (27.8%), the diag-
nosis was confirmed by skin biopsy. All of the specimens
were examined by the same histopathologist. The histologi-
cal confirmation was based on the presence of degeneration
of the basal layer with band like lymphocytic infiltration of
the papillary dermis.
Table 1: Distribution of patients with LP in relation to their age and sex.
sex Age (years) Total
0e9 (%) 10e19 (%) 20e29 (%) 30e39 (%) 40e49 (%) 50e59 (%) 60e69 70e79
Males 2 (2.1) 5 (5.2) 8 (8.2) 20 (20.6) 10 (10.3) 2 (2.1) 2 (2.1) 2 (2.1) 50 (51.5)
Females 4 (4.1) 5 (5.2) 9 (9.3) 16 (16.5) 5 (5.2) 5 (5.2) 3 (3.1) 0 (0) 47 (48.5)
Total 6 (6.2) 10 (10.3) 17 (17.5) 36 (37.1) 15 (15.5) 7 (7.2) 5 (5.2) 1 (1) 97 (100)
A study of lichen planus224Blood samples were obtained from all patients for esti-
mation of plasma glucose and liver enzymes.
The control group was selected by systemic random
sampling method. The total number of healthy blood donors
from both sexes and of different age groups, who donated
blood in the Central Blood Bank of Basra during the same
period of cases, collection (103,450 people), were divided into
groups of fifties In each group, the number 6 was selected by
chance and the 6th of each 50 was taken as a control. The
number of controls that had been extracted by the afore-
mentioned statistical method was 2070.
Pooled data were analysed using Statistical Package for
the Social Sciences (SPSS) (ver.15) software. Fisher’s exact
test was used to test the significance of association between
lichen planus and HCV. In the comparison between cases
and controls, p value less than 0.05 was considered as
significant.Results
Three patients (3.1%) out of 97 with LP had positive
serological test for anti-HCV antibody compared with the
control group in which the prevalence of anti-HCV antibody
was estimated to be 0.14%, p value ¼ 0.002.
The peak of LP was in the age group 30e39 years in both
sexes and represents 36 (37.1%) of total cases followed by the
age group 40e49 in 10 males (10.3%) and 20e29 in nine
females (9.3%). The lowest prevalence of LP 1 (1%) was
recorded in the age group 70e79 as shown in Table 1. There
were 16 patients under 20 and represented (16.5%) of the
total cases.
The skin condition predominated over other sites of
involvement in both sexes; females 6 (75%) presented with
oral lesions more than males 2 (25%) while males 13 (76.5%)
had generalized LP compared to females 4 (23.5%). The sex
distribution of patients and the site of LP are shown in
Table 2.
The commonest type of LP encountered during this study
was the classical type which accounts for 36 cases (37.1%)
followed by the hypertrophic and oral types with frequency
of 20 (20.6%) and 9 (9.3%), respectively.Table 2: Sex distribution of various sites of Lp among all patients.
Sex Site
Skin (%) Generalized (%) Oral (
Males 34 (48.6) 13 (76.5) 2 (25)
Females 36 (51.4) 4 (23.5) 6 (75)
Total 70 (100) 17 (100) 8 (100The sex distribution of patients in reference to the type of
LP is shown in Table 3. Classical LP is the commonest type in
both sexes, 19 males (38%) and 17 females (36.2%). The oral
type is seen more in females 7 (14.9%) compared with their
male counterparts only 2 (4%) of whom were affected. The
Atrophic and annular types were seen exclusively in males
while the hypertrophic type was seen more in males.
All the patients with positive serological test of HCV were
males 3 (6%). No significant differences were found between
both sexes in those with negative serology, p value ¼ 0.24.
Two of the three cases with serological evidence of HCV had
oral reticulate lesions.
Only one (33.3%) of the three patients who were HCV
positive had elevated plasma glucose compared to 13
(13.8%) out of 94 who were HCV seronegative; however,
there is no significant difference between the two groups, p
value ¼ 0.37.
Abnormal liver function test (LFT) were found in 23
(23.7%) of patients with LP none of whom were anti-HCV
positive. The distribution of LFT in different age groups is
shown in Table 4. Those younger than 20 years had the
highest incidence of abnormal LFT, 12 (52.1%) compared
to 11 (47.9%) from other age groups. This abnormality
was due to isolated elevation in ALP in the first group and
in aminotransferases in the second group.
All of the three patients who were HCV positive had
normal LFT compared to 71 (75.5%) of the HCV negative
group with 23 (24.5%) abnormal LFT.
Discussion
LP is a pruritic, purplish, plane, polygonal papular
eruption. It is seen most commonly on the flexor surface of
the wrist and legs, genitalia and mucous membranes. More
than 50% of cutaneous lesions resolve within 6 months and
85% of cases resolve within 18 months. However, oral le-
sions have a mean duration of 5 years.9
In recent years it has become known that HCV induces a
broad spectrum of extrahepatic manifestations including
LP.8 The first case was reported in France in 1991.15
The prevalence of HCV antibodies in patients with oral
and cutaneous LP was found to be significantly higher thanTotal (%)
%) Scalp (%) Genital (%)
0 (0) 1 (100) 50 (51.5)
1 (100) 0 (0) 47 (48.5)
) 1 (100) 1 (100) 97 (100)
Table 3: sex distribution of patients in relation to the type of LP.
Sex Type Total
Oral
(%)
Classical
(%)
Actinic
(%)
Follicular
(%)
Pigmented
(%)
Annular
(%)
Hypertrophic
(%)
Acute
(%)
Guttate
(%)
Bullous
(%)
Atrophic
(%)
Males 2 (4) 19 (38) 1 (2) 1 (2) 3 (6) 4 (8) 13 (26) 4 (8) 1 (2) 1 (2) 1 (2) 50 (100)
Females 7 (14.9) 17 (36.2) 7 (14.9) 1 (2.1) 1 (2.1) 0 (0) 7 (14.9) 4 (8.5) 2 (4.3) 1 (2.1) 0 (0) 47 (100)
Total 9 (9.3) 36 (37.1) 8 (8.2) 2 (2.1) 4 (4.1) 4 (4.1) 20 (20.6) 8 (8.2) 3 (3.1) 2 (2.1) 1 (1) 97 (100)
S.K. Strak et al. 225that in the control group in Jordan,7 Kingdom of Saudi
Arabia,9 Turkey16 and Iran.17,18
In this study HCV antibody prevalence in patients with
LP was 3.1%. It was significantly higher in the blood donors
(0.14%) who were in the control group (p value ¼ 0.002).
However, the prevalence of HCV among the control group
was substantially lower than in other countries like north
Egypt8 (38%) and USA19 (1.4%). This may be attributed to
the highest prevalence of intravenous drug users in developed
countries like USA and the use of infected parenteral
antimony treatment for schistosomiasis in Egypt. In
addition to this, no studies have been carried out in Basra
to estimate the real prevalence in the general population.
One of the limitations of this study is that the control
group was non-representative of the general population as
they were healthy individuals.
For some authors the association of LP and positive
serology for HCV, even positive RNA, is not a substantive
enough reason to determine the role of HCV in the patho-
genesis of LP. Nevertheless, demonstration of HCV RNA in
epithelial cells of oral mucosa20,21 and skin lesions6,22,23 of
patients with LP would lead to the theory that direct
action of the virus is involved.
It was found that 36 patients (37.1%) were in their 4th
decade which matches what had been written in studies.4,24
LP is rare in children.1,3 An interesting finding in our study
is that 16 patients (16.5%) were under the age of 20. This
may be attributed to the hepatitis B vaccine and there are
reported cases of LP secondary to hepatitis B vaccination25
keeping in mind that the hepatitis B vaccine has been
included in the expanded programme of immunization
(EPI) in Iraq since 1992.Table 4: distribution of LFT in regard to age groups.
Age group (years) LFT
Normal (%)
0e9 1 (16.7)
10e19 3 (30)
20e29 16 (94.1)
30e39 32 (88.9)
40e49 12 (80)
50e59 5 (71.4)
60e69 4 (80)
70e79 1 (100)
Total (%) 74 (76.3)
LFT: liver function tests.The majority of patients with LP in this study 70 (72.2%)
had skin involvement which was similar to that found in
other studies.17,26 However, two studies9,16 found that
(46.6%) and (53.4%) had generalized LP (skin and oral),
respectively. Another study13 found oral lesion being the
commonest.
In oral LP, women outnumber men by more than 2:13,27
which concords with the findings in this study where the
majority of patients were females. Furthermore, females
were more likely to be affected by erosive oral LP in contrast
to males who more commonly suffered from reticulate oral
lesions. Mechanical injury from dental procedures and poor
fitting appliances may trigger or exacerbate gingival LP
probably via the Koebner’s phenomenon.27 Al-Hamdi28
found that chewing of deram (juglans) which is a herbal
remedy used widely by women in the southern part of Iraq
for cosmetic purposes plays a role in the pathogenesis of
LP. This may explain the above findings, at least among
Iraqi female patients.
All of the three seropositive cases were males but there
was neither clinical nor biochemical correlation between
these cases apart from the fact that two of them had retic-
ulate oral lesions. This finding disagrees with other
studies7,17 where the erosive type was found to be the
commonest.
No significant association was found between high
plasma glucose and HCV seropositivity, however, Al-
Tarawneh et al.7 found that RBS were significantly higher
in HCV positive patients and recommended its use as a
routine investigation in every patient afflicted by LP.
In this study 23 patients (32.7%) with LP had abnormal
LFTand none of them had HCV antibodies. 12 (52%) ofTotal (%)
Abnormal (%)
5 (83.3) 6 (100)
7 (70) 10 (100)
1 (5.9) 17 (100)
4 (11.1) 36 (100)
3 (20) 15 (100)
2 (28.6) 7 (100)
1 (20) 5 (100)
0 (0) 1 (100)
23 (23.7) 97 (100)
A study of lichen planus226these patients were under 20 and had isolated hyper-
phosphatasia (elevated alkaline phosphatase). This can be
explained by the normal finding of hyperphosphatasia
encountered in the growing bone. On the other hand, two of
the 11 patients (48%), who were over 20 and presented
abnormal LFT, had elevation in all the three enzymes. One
of these two patients was a 37-year-old female suffering from
Hodgkin’s disease and undergoing chemotherapy. The
remaining nine patients had elevation in either two or one of
the transaminases. This may be attributed to agents causing
hepatic insult other than hepatitis B or C.
Conclusion
A statistically significant high prevalence of HCV (3.1%)
is detected in Iraqi patients living in Basra with LP.
Recommendation
It seems that screening for HCV would be cautious in
patients with LP even in those with normal LFT. Derma-
tologists should request hepatitis screening before attempt-
ing skin biopsy for every patient with LP.
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